Revolutions Medical Signs Definitive Manufacturing and Supply Agreement With Yeso-med


CHARLESTON, S.C., Dec. 1, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation (OTCQB:RMCP) ("Revolutions Medical" or the "Company") announced today that it has signed a definitive manufacturing agreement with the Wuxi Yushou Medical Appliance Co., Ltd. ("Yeso-med"). The agreement includes all sizes of the RevVac™ auto-retractable vacuum safety syringe (1ml, 3ml, 5ml, and 10ml), all of which will be manufactured in the new Yeso-med workshop. The new Yeso-med facility is over 215,000 square feet and includes 15 injection molding machines and several lines of production. The new facility can scale to a capacity of 300,000,000 units annually. Yeso-med is currently producing the 3ml RevVac™ safety syringe and plans to have all other sizes in production by the end of the 2nd quarter of 2012. 

Revolutions Medical selected Yeso-med as their exclusive manufacturer in China based on more than a decade of producing quality medical products, a sophistication of specific safety syringe manufacturing, and the financial commitment and dedication to getting the RevVac™ safety syringe to the market.  Yeso-med has FDA, CE Mark, and Anvisa certifications and meets all relevant ISO standards. Yeso-med will also have the opportunity to directly distribute to new and existing clients.

Ron Wheet, Chief Executive Officer and Chairman of Revolutions Medical, stated, "Now that the production of our RevVac™ safety syringes are secured with our agreement with Yeso-med, the Company can now start scheduling shipping dates and begin to fulfill sales orders." He continued, "Since June of this year, the Company has embarked on a marketing strategy that included online direct sales, industry conferences and tradeshows, and contacting international and domestic medical product distributors."

About Revolutions Medical Corporation

Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™ and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).

For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com

To be added to the Revolutions Medical investor email list, please email: investment@revolutionsmedical.com with RMCP in the subject line.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.


            

Contact Data